Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Fatigue 9Glioma 3Sleep Initiation and Maintenance Disorders 2Neoplasms 2Central Nervous System Neoplasms 2cyclopia sequence 1Unspecified Adult Solid Tumor, Protocol Specific 1Sleep Wake Disorders 1Oligodendroglioma 1Neurotoxicity Syndromes 1Nervous System Neoplasms 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Esophageal Neoplasms 1Ependymoma 1Cognition Disorders 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Therapeutics 1Sorafenib 1Paclitaxel 1Oxaliplatin 1Modafinil 1Mental Status and Dementia Tests 1Medication Therapy Management 1Interferon-gamma 1Gemcitabine 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Unspecified Adult Solid Tumor, Protocol Specific × Modafinil × Clear all
NCT01019187 2020-04-09

Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
226 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡